Thiotepa 100 mg/1 (Thiotepa INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 100 mg/1

Thiotepa 100 mg/1 is a lyophilized powder for solution, used for various medical conditions. This injectable medication is manufactured by Hikma Pharmaceuticals USA Inc. and is available in a 100 mg/1 strength.

Strength

100 mg/1

Pack Size

1 VIAL in 1 BOX, UNIT-DOSE (0143-9292-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIA

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Thiotepa is commonly used for its antineoplastic properties, often in the treatment of certain cancers. It may be administered intravenously, intracavitarily, or intravesically, depending on the specific medical protocol. Thiotepa 100 mg/1 is typically prescribed by healthcare professionals to address conditions requiring chemotherapy.

Side Effects

Thiotepa can cause various effects, including nausea, vomiting, and bone marrow suppression. Patients may also experience fatigue and changes in blood cell counts. These effects can vary widely among individuals and should be monitored by a healthcare provider.

Precautions & Warnings

Thiotepa should be handled with care, as it is a potent medication. It is important to follow the instructions provided by a healthcare professional regarding administration and storage. Patients should be aware of potential side effects and report any severe reactions to their doctor immediately.

Avoid Interactions

Thiotepa may interact with other medications, including those that affect the bone marrow or immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of Thiotepa.

Frequently Asked Questions

Thiotepa is primarily used for its antineoplastic properties, often in the treatment of certain cancers.

Thiotepa can be administered intravenously, intracavitarily, or intravesically, depending on the specific medical protocol.

Common side effects of Thiotepa include nausea, vomiting, bone marrow suppression, fatigue, and changes in blood cell counts.

Thiotepa may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Thiotepa should be handled with care and administered under the guidance of a healthcare professional. Patients should be aware of potential side effects and report any severe reactions immediately.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.